Researchers recently developed two novel compounds that target the same subtype of serotonin receptors as LSD and psilocybin but do not produce hallucinations. Like psychedelic substances, these novel ...
Researchers have designed compounds that hit the same key receptor that LSD activates without causing hallucinations, according to an article (“Bespoke library docking for 5-HT 2A receptor agonists ...
Psilocybin — the main psychedelic compound in magic mushrooms — is the most famous and best-studied psychedelic substance. But beyond psilocybin, there are many other psychedelic compounds, some ...
New treatments for mental health and behavioral disorders are desperately needed. Rates of depression, anxiety, PTSD, and substance use disorders soared during the pandemic, and traditional ...
Hosted on MSN
Neuroscientists just rewrote our understanding of psychedelics with a groundbreaking receptor-mapping study
Classical psychedelics act on a surprisingly broad range of brain receptors, not just the serotonin receptor long associated with their hallucinogenic effects, according to new research published in ...
Scientists Discover Multiple Pathways of the Main Receptor Activated by Psychedelics Scientists have designed compounds that hit the same key receptor that LSD activates without causing hallucinations ...
ZUG, Switzerland, Feb. 11, 2021 /PRNewswire/ -- MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), a leading psychedelic medicine biotech company announced a new partnership with Swiss startup MindShift ...
Psychedelics belong to a group of compounds called psychoplastogens, which can promote neuronal growth and restore atrophied connections in the brain. This ability makes the molecules promising as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback